Charming Medical dismantles dual-class shares, CEO locks up stake, and adopts U.S. governance standards
MCTA has more than doubled off its 52-week low of $4.3 on elevated volume (4.9× avg).
Summary
Charming Medical voluntarily abolishes its dual-class share structure, the CEO locks up shares for one year, and the company adopts U.S. domestic governance standards — a sweeping overhaul that could improve investor perception and listing prospects.
Key Events · Corporate Governance and Compliance · MCTA
-
Dual-Class Structure Abolished
CEO Kit Wong irrevocably surrendered all 2,000,000 Class B Ordinary Shares (20 votes each) for cancellation, eliminating the dual-class structure. Post-surrender, voting power shifts to one vote per share, with Ms. Wong holding ~68.19% of the 15,178,000 outstanding Ordinary Shares.
-
CEO Enters One-Year Lock-Up
Ms. Wong agreed not to sell, pledge, or hedge any of her Class A Ordinary Shares or equivalents for one year, signaling long-term commitment and removing near-term overhang.
-
Adopts U.S. Domestic Governance Standards
The company voluntarily relinquished foreign private issuer exemptions under Nasdaq Rule 5615(a)(3), committing to comply with all U.S. domestic listing rules including board/committee composition, shareholder approval for issuances, and proxy solicitation requirements.
-
Shareholder Vote Planned
A shareholder meeting will be convened to amend the memorandum and articles of association, formally abolishing the dual-class share structure.
Analysis · MCTA · Industrial Applications And Services
In a sweeping governance overhaul, Charming Medical is voluntarily dismantling its dual-class share structure. CEO Kit Wong surrendered all 2 million super-voting Class B shares for no consideration, eliminating the 20:1 voting ratio and reducing her voting power from roughly 91% to 68% on a one-share-one-vote basis. At the same time, the company is opting into full Nasdaq U.S. domestic governance standards, abandoning foreign private issuer exemptions, and the CEO has locked up her entire equity stake for one year. These moves directly address governance concerns that often weigh on foreign-listed Chinese companies and could be a precursor to regaining Nasdaq compliance or restoring investor confidence. The filing also flags that trading resumption and continued listing remain uncertain, so the governance overhaul may be part of a broader effort to satisfy exchange or regulatory requirements.
At the time of this filing, MCTA was trading at $29.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $438.5M. The 52-week trading range was $4.30 to $31.70. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.